/ Natco Launches Pomalid First Generic Version Of Pomalidomide Capsules In India ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Wednesday, 10 May 2017

Natco Pharma Limited on Wednesday, 10 May 2017, in its BSE filing said that it has launched a generic version of pomalidomide 1 mg, 2 mg, and 4 mg capsules in India.

Pomalidomide is sold by Celgene Inc., in the USA, under the brand name POMALYST. Pomalidomide is a thalidomide analogue indicated, in combination with dexamethasone, for patients with multiple myeloma (a type of blood cancer) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy, it said.

Natco will market generic pomalidomide capsules under its brand name POMALID in India. Natco priced its generic medicine of POMALID 1 mg, 2 mg, and 4 mg capsules at an MRP of INR 5000/-, INR 10,000/-, and INR 20,000/- respectively for a monthly pack of 21 capsules.

We believe this is approximately 98% discount of price from what it is sold at in the USA to patients, per secondary market data researched, added Natco.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717